martes, 6 de enero de 2026

Lymphoma in the BiTE era The Lancet Haematology +++ +...

Lymphoma in the BiTE era The Lancet Haematology https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(25)00344-8/fulltext?dgcid=raven_jbs_etoc_email Intravenous iron for non-anaemic iron deficiency in pregnancy: a multicentre, two-arm, randomised controlled trial Tayyiba Wasim, FRCOGa ∙ Natasha Bushra, MRCOGa ∙ Tahira Nasrin, FCPSa ∙ Shamsa Humayun, FCPSb ∙ Arif Tajammul, FRCOGc ∙ Khadija Irfan Khawaja, FCPSa ∙ et al https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(25)00315-1/abstract?dgcid=raven_jbs_etoc_feature_lanhae Iberdomide plus low-dose cyclophosphamide and dexamethasone in patients with relapsed and refractory multiple myeloma (the ICON study): a multicentre, single-arm, phase 2 trial Charlotte L B M Korst, MDa ∙ Wouter Plattel, MD PhDb ∙ Elizabeth A de Kort, MD PhDc ∙ Febe Smits, MDa,d ∙ Alexandra J Croockewit, MD PhDc ∙ Mark-David Levin, MD PhDe ∙ et al. https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(25)00298-4/abstract?dgcid=raven_jbs_etoc_feature_lanhae Jan 2026 Volume 13Number 1e1-e54 https://www.thelancet.com/journals/lanhae/issue/vol13no1/PIIS2352-3026(25)X0013-2

No hay comentarios:

Publicar un comentario